Table 1.

Clinical characteristics of 13 patients with extragastrointestinal stromal tumor (EGIST) and the immunohistochemical findings.

No	Age	Gender	Location	Clinic	Tumor size (cm)	Risk Score	Rec.	Met.	c-kit	Histologic type	s 100	Ki-67	SMA	CD34	Mitotic index	Lymph node	OS (m)
1	33	F	Jejunum sac	AP	22	High	−	M (L)	100	Mixed	–	60	–	–	35/50	–	49
2	53	M	Intra-abdominal	AP	4	Intermediate	+	NM	100	Spindle	–	10	–	–	4/50	–	72
3	71	F	Intra-abdominal	E	15	High	+	NM	90	Mixed	–	3	50	100	2/50	–	11 (d)
4	47	M	Retroperitoneal	AP	24	High	−	NM	100	Spindle	–	7	–	100	4/50	–	70
5	56	F	Intra-abdominal	AP	19	High	−	NM	100	Mixed	–	20	–	100	37/50	–	82
6	72	F	Intra-abdominal	B	5	Intermediate	−	NM	100	Mixed	–	2	–	–	0/50	–	62 (d)
7	51	M	Intra-abdominal	B	26	High	−	NM	50	Spindle	–	11	–	–	6/50	–	8 (d)
8	58	M	Intra-abdominal	AP	24	High	−	M (O)	50	Mixed	–	7	–	50	38/50	–	22 (d)
9	83	M	Intra-abdominal	AP	6	Intermediate	−	NM	50	Mixed	–	1	–	–	1/50	–	22 (d)
10	65	M	Intra-abdominal	E	26	High	+	NM	100	Mixed	–	12	10	50	20/50	–	21 (d)
11	39	F	Intra-abdominal	E	5	Low	−	NM	50	Spindle	10	8	10	–	0/50	–	84
12	72	F	Intra-abdominal	AP	16	High	−	NM	50	Mixed	–	8	–	–	0/50	–	21 (d)
13	75	M	Intra-abdominal	E	30	High	−	NM	100	Mixed	–	12	–	40	21/50	–	11 (d)

F – Female; M – Male; AP – abdominal pain; B – bleeding; E – detected during examination; Rec – recurrence, (+) – positive; (−) – negative; Met – metastasis; M – metastasic; NM – non-metastatic; L – liver; 0 – omentum; D – desmin; S100 – Ki-67; SMA – smooth muscle antigen; OS(m) – overall survival (months); (d) – death due to disease.